Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Synlogic Inc.
DescriptionLive E. coli Nissle bacterium microbiome modified to assimilate ammonia
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationUrea cycle disorder (UCD)
Indication Details Treat urea cycle disorder (UCD)
Regulatory Designation U.S. - Orphan Drug ( Treat urea cycle disorder (UCD))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today